BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11557626)

  • 41. In vivo effect of recombinant human granulocyte colony-stimulating factor on neutrophilic expression of CD11b in septic neonates: a randomized controlled trial.
    El-Ganzoury MM; El-Farrash RA; Saad AA; Mohamed AG; El-Sherbini IG
    Pediatr Hematol Oncol; 2012 Apr; 29(3):272-84. PubMed ID: 22475305
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of recombinant human granulocyte colony-stimulating factor (rhG-CSF) therapy in granulopoetic patients complicated with sepsis.
    Endo S; Inada K; Inoue Y; Yamada Y; Takakuwa T; Kasai T; Nakae H; Kuwata Y; Hoshi S; Yashida M
    Curr Med Res Opin; 1994; 13(4):233-41. PubMed ID: 7533691
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential role of CD18 integrins in mediating lung neutrophil sequestration and increased microvascular permeability induced by Escherichia coli in mice.
    Gao X; Xu N; Sekosan M; Mehta D; Ma SY; Rahman A; Malik AB
    J Immunol; 2001 Sep; 167(5):2895-901. PubMed ID: 11509637
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mature and immature myeloid cells decrease the granulocyte colony-stimulating factor level by absorption of granulocyte colony-stimulating factor.
    Saito K; Nakamura Y; Waga K; Hirota K; Inoue F; Enokihara H; Nara N; Furusawa S
    Int J Hematol; 1998 Feb; 67(2):145-51. PubMed ID: 9631581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The effectiveness of hemopoietic growth factors in sepsis].
    Yilmaz G; Aldemir M; Yilmaz R; Diken H; Büyükbayram H; Akgün Y
    Ulus Travma Derg; 2001 Apr; 7(2):82-6. PubMed ID: 11705042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
    Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
    Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis.
    Schibler KR; Osborne KA; Leung LY; Le TV; Baker SI; Thompson DD
    Pediatrics; 1998 Jul; 102(1 Pt 1):6-13. PubMed ID: 9651406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission.
    Weiss M; Voglic S; Harms-Schirra B; Lorenz I; Lasch B; Dumon K; Gross-Weege W; Schneider EM
    Intensive Care Med; 2003 Jun; 29(6):904-914. PubMed ID: 12682721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Granulocyte colony-stimulating factor and antibiotics in the prophylaxis of a murine model of polymicrobial peritonitis and sepsis.
    Villa P; Shaklee CL; Meazza C; Agnello D; Ghezzi P; Senaldi G
    J Infect Dis; 1998 Aug; 178(2):471-7. PubMed ID: 9697729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of recombinant canine granulocyte colony-stimulating factor on white blood cell production in clinically normal and neutropenic dogs.
    Mishu L; Callahan G; Allebban Z; Maddux JM; Boone TC; Souza LM; Lothrop CD
    J Am Vet Med Assoc; 1992 Jun; 200(12):1957-64. PubMed ID: 1379221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans.
    Chiller T; Farrokhshad K; Brummer E; Stevens DA
    Med Mycol; 2002 Feb; 40(1):21-6. PubMed ID: 11860010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial.
    Drossou-Agakidou V; Kanakoudi-Tsakalidou F; Sarafidis K; Taparkou A; Tzimouli V; Tsandali H; Kremenopoulos G
    Eur J Pediatr; 1998 Jul; 157(7):583-8. PubMed ID: 9686822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exogenous carbon monoxide suppresses Escherichia coli vitality and improves survival in an Escherichia coli-induced murine sepsis model.
    Shen WC; Wang X; Qin WT; Qiu XF; Sun BW
    Acta Pharmacol Sin; 2014 Dec; 35(12):1566-76. PubMed ID: 25399652
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic efficacy of granulocyte colony stimulating factor against rat cecal ligation and puncture model.
    Toda H; Murata A; Matsuura N; Uda K; Oka Y; Tanaka N; Mori T
    Stem Cells; 1993 May; 11(3):228-34. PubMed ID: 7686420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. G-CSF and GM-CSF for treating or preventing neonatal infections.
    Carr R; Modi N; Doré C
    Cochrane Database Syst Rev; 2003; 2003(3):CD003066. PubMed ID: 12917944
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.
    Presneill JJ; Waring PM; Layton JE; Maher DW; Cebon J; Harley NS; Wilson JW; Cade JF
    Crit Care Med; 2000 Jul; 28(7):2344-54. PubMed ID: 10921563
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Granulocyte-macrophage colony-stimulating factor (GM-CSF) but not granulocyte colony-stimulating factor (G-CSF) induces plasma membrane expression of proteinase 3 (PR3) on neutrophils in vitro.
    Hellmich B; Csernok E; Trabandt A; Gross WL; Ernst M
    Clin Exp Immunol; 2000 May; 120(2):392-8. PubMed ID: 10792393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor and neutrophils in the bronchoalveolar lavage fluid of premature infants with respiratory distress syndrome.
    Papoff P; Christensen RD; Calhoun DA; Juul SE
    Biol Neonate; 2001 Aug; 80(2):133-41. PubMed ID: 11509813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of recombinant canine granulocyte-colony stimulating factor to increase leukocyte count in dogs naturally infected by canine parvovirus.
    Armenise A; Trerotoli P; Cirone F; De Nitto A; De Sario C; Bertazzolo W; Pratelli A; Decaro N
    Vet Microbiol; 2019 Apr; 231():177-182. PubMed ID: 30955806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.